prostatic carcinoma
BACKGROUND: The present pilot study tested the clinical performance of a new       pharmacokinetically guided dosing regimen of parenteral estrogen in patients with       advanced prostatic carcinoma.
BACKGROUND: The present pilot study tested the clinical performance of a new       pharmacokinetically guided dosing regimen of parenteral estrogen in  @OBJECT$   @PREDICAT$        advanced  @SUBJECT$ .